Focal Muscle Vibration Improves Gait in Parkinson's Disease: A Pilot Randomized, Controlled Trial

被引:12
|
作者
Camerota, Filippo [1 ]
Celletti, Claudia [1 ]
Suppa, Antonio [2 ,3 ]
Galli, Manuela [4 ,5 ]
Cimolin, Veronica [4 ]
Filippi, Guido Maria [6 ]
La Torre, Giuseppe [7 ]
Albertini, Giorgio [5 ]
Stocchi, Fabrizio [5 ]
De Pandis, Maria Francesca [8 ]
机构
[1] Sapienza Univ, Umberto Hosp, Phys Med & Rehabil Div, Rome, Italy
[2] Sapienza Univ Rome, Dept Neurol & Psychiat, Rome, Italy
[3] Sapienza Univ Rome, Neuromed Inst, Rome, Italy
[4] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy
[5] Tosinvest Sanita, IRCCS San Raffaele Pisana, Rome, Italy
[6] Catholic Univ, Inst Human Physiol, Rome, Italy
[7] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
[8] Tosinvest Sanita, IRCCS San Raffaele Cassino, Cassino, Italy
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2016年 / 3卷 / 06期
关键词
gait analysis; muscle vibration; Parkinson's disease; rehabilitation; sensorimotor integration;
D O I
10.1002/mdc3.12323
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In Parkinson's disease (PD), gait disorders lead to increased risk of falls and patients' reduced participation and independence. Several observations suggest that a single session of focal muscle vibration (fMV) applied to trunk or lower limb muscles during gait may improve several gait variables in patients with PD. The possible long-term beneficial effects of repetitive sessions of fMV (r-fMV) on gait of patients with PD have been investigated. Methods: A randomized, controlled trial study has been conducted in an outpatient rehabilitation department. Twenty patients with PD diagnosis have been randomized in two groups: " real" or "sham" r-fMV application to quadriceps and paraspinal muscles in patients with PD. Gait was evaluated with objective gait analysis, and a number of variables, including velocity, step length, stride length, percentage of stance, double support duration, cadence, swing velocity, and step width, have been measured. Gait analysis was performed before and 24 hours and 1 and 3 weeks after r-fMV. Results: After real, but not sham, r-fMV, patients with PD had significant gait improvement as a result of increased walking velocity and stride length. The r-fMV-induced beneficial after effects lasted at least 1 week after the end of stimulation. Conclusions: Data emerging from our pilot randomized, controlled trial study suggest that r-fMV may improve gait disorders in patients with PD. r-fMV might be a feasible, safe approach for possibly improving gait disorders in patients with PD and might enhance the impact of specific rehabilitation programs in PD.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 50 条
  • [31] The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson's disease: A randomized controlled trial
    Eldemir, Sefa
    Eldemir, Kader
    Saygili, Fettah
    Ozkul, Cagla
    Yilmaz, Rezzak
    Akbostanci, Muhittin Cenk
    Guclu-Gunduz, Arzu
    BRAIN AND BEHAVIOR, 2024, 14 (03):
  • [32] Focal muscle vibration as a possible intervention to prevent falls in elderly women: a pragmatic randomized controlled trial
    Celletti, Claudia
    Fattorini, Luigi
    Camerota, Filippo
    Ricciardi, Diego
    La Torre, Giuseppe
    Landi, Francesco
    Filippi, Guido Maria
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 27 (06) : 857 - 863
  • [33] A pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers
    Leroi, Iracema
    Baker, Peter
    Kehoe, Pam
    Daniel, Emily
    Byrne, E. Jane
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (10) : 1073 - 1079
  • [34] Increasing Access to Specialty Care: A Pilot, Randomized Controlled Trial of Telemedicine for Parkinson's Disease
    Dorsey, E. Ray
    Deuel, Lisa M.
    Voss, Tiffini S.
    Finnigan, Kara
    George, Benjamin P.
    Eason, Sheelah
    Miller, David
    Reminick, Jason I.
    Appler, Anna
    Polanowicz, Joyce
    Viti, Lucy
    Smith, Sandy
    Joseph, Anthony
    Biglan, Kevin M.
    MOVEMENT DISORDERS, 2010, 25 (11) : 1652 - 1659
  • [35] Muscle strength and spatiotemporal gait parameters in people with Parkinson's disease. A pilot study
    Fernandez-Vazquez, Diego
    Molina-Rueda, Francisco
    Navarro-Lopez, Victor
    Straudi, Sofia
    Cano-de-la-Cuerda, Roberto
    REVISTA DE NEUROLOGIA, 2023, 77 (05) : 115 - 124
  • [36] Treadmill training improves overground walking economy in Parkinson's disease: a randomized, controlled pilot study
    Angel Fernandez-del-Olmo, Miguel
    Andres Sanchez, Jose
    Bello, Olalla
    Lopez-Alonso, Virginia
    Marquez, Gonzalo
    Morenilla, Luis
    Castro, Xabier
    Giraldez, Manolo
    Santos-Garcia, Diego
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [37] Transcranial direct current stimulation associated with gait training in Parkinson's disease: A pilot randomized clinical trial
    Costa-Ribeiro, Adriana
    Maux, Ariadne
    Bosford, Thamyris
    Aoki, Yumi
    Castro, Rebeca
    Baltar, Adriana
    Shirahige, Livia
    Moura Filho, Alberto
    Nitsche, Michael A.
    Monte-Silva, Katia
    DEVELOPMENTAL NEUROREHABILITATION, 2017, 20 (03) : 121 - 128
  • [38] Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson’s disease
    Heiko Gaßner
    Elmar Trutt
    Sarah Seifferth
    Jana Friedrich
    Diana Zucker
    Ziad Salhani
    Werner Adler
    Jürgen Winkler
    Wolfgang H. Jost
    Journal of Neural Transmission, 2022, 129 : 1189 - 1200
  • [39] Leg muscle power is enhanced by training in people with Parkinson's disease: a randomized controlled trial
    Paul, Serene S.
    Canning, Colleen G.
    Song, Jooeun
    Fung, Victor S. C.
    Sherrington, Catherine
    CLINICAL REHABILITATION, 2014, 28 (03) : 275 - 288
  • [40] Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study
    Zhang, Heng
    Cao, Xing-yue
    Wang, Li-na
    Tong, Qing
    Sun, Hui-min
    Gan, Cai-ting
    Shan, Ai-di
    Yuan, Yong-sheng
    Zhang, Ke-zhong
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (12) : 3889 - 3900